Package 0078-0683-61

{"route": ["INTRAVENOUS"], "spl_id": "b1a3f864-56e1-44da-b2d0-7158d0945513", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["60158CV180"], "rxcui": ["603566", "616366"], "spl_set_id": ["fffa5d75-0dba-4ad7-a252-5f60fa28489a"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL (0078-0683-61)", "package_ndc": "0078-0683-61", "marketing_end_date": "20260930", "marketing_start_date": "20190802"}], "brand_name": "Arranon", "product_id": "0078-0683_b1a3f864-56e1-44da-b2d0-7158d0945513", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0078-0683", "generic_name": "nelarabine", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Arranon", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "NDA021877", "marketing_category": "NDA", "marketing_end_date": "20260930", "marketing_start_date": "20161005"}